Cinolazepam: Difference between revisions

	WikiDoc Resources for Cinolazepam
Articles
Most recent articles on Cinolazepam Most cited articles on Cinolazepam Review articles on Cinolazepam Articles on Cinolazepam in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cinolazepam Images of Cinolazepam Photos of Cinolazepam Podcasts & MP3s on Cinolazepam Videos on Cinolazepam
Evidence Based Medicine
Cochrane Collaboration on Cinolazepam Bandolier on Cinolazepam TRIP on Cinolazepam
Clinical Trials
Ongoing Trials on Cinolazepam at Clinical Trials.gov Trial results on Cinolazepam Clinical Trials on Cinolazepam at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cinolazepam NICE Guidance on Cinolazepam NHS PRODIGY Guidance FDA on Cinolazepam CDC on Cinolazepam
Books
Books on Cinolazepam
News
Cinolazepam in the news Be alerted to news on Cinolazepam News trends on Cinolazepam
Commentary
Blogs on Cinolazepam
Definitions
Definitions of Cinolazepam
Patient Resources / Community
Patient resources on Cinolazepam Discussion groups on Cinolazepam Patient Handouts on Cinolazepam Directions to Hospitals Treating Cinolazepam Risk calculators and risk factors for Cinolazepam
Healthcare Provider Resources
Symptoms of Cinolazepam Causes & Risk Factors for Cinolazepam Diagnostic studies for Cinolazepam Treatment of Cinolazepam
Continuing Medical Education (CME)
CME Programs on Cinolazepam
International
Cinolazepam en Espanol Cinolazepam en Francais
Business
Cinolazepam in the Marketplace Patents on Cinolazepam
Experimental / Informatics
List of terms related to Cinolazepam

VisualWikitext

Latest revision as of 14:47, 8 April 2015

This image is provided by the National Library of Medicine.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cinolazepam^[1] (marketed under the brand name Gerodorm)^[2] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as an hypnotic. Cinolazepam is not approved for sale in the United States or Canada.

References

↑ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
↑ Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006.

Template:Benzodiazepines

[1] US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof

[Gerodorm-2] Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006.

[1]

[2]

@@ Line 1: / Line 1: @@
-{{Drugbox|
+<div style="float: right;">
-|IUPAC_name = ''3-[9-chloro-6-(2-fluorophenyl)-4-hydroxy-3-oxo-2,5-diazabicyclo''<br />''[5.4.0]undeca-5,8,10,12-tetraen-2-yl]propanenitrile''
+[[File:Cinolazepam.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div>
-| image = Cinolazepam.svg
+__NOTOC__
-| width=215
+{{SI}}
-| image2 = Cinolazepam3d.png
+{{CMG}}
-| CAS_number=75696-02-5
+==Overview==
-| ATC_prefix=N05
+'''Cinolazepam'''<ref> US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof</ref> (marketed under the brand name '''Gerodorm''')<ref name=Gerodorm>{{cite web | url = http://www.lannacher.ro/gerodorm.html | title = Gerodorm | accessdate = 17 August 2006 | author = Lannacher Romania | year = 1999 | work = Produse Gerot inregistrate in Romania | language = Romanian |archiveurl = http://web.archive.org/web/20061011022835/http://www.lannacher.ro/gerodorm.html <!-- Bot retrieved archive --> |archivedate = 11 October 2006}}</ref> is a drug which is a [[benzodiazepine]] derivative. It possesses [[anxiolytic]], [[anticonvulsant]], [[sedative]] and [[skeletal muscle relaxant]] properties.
-| ATC_suffix=CD13
+Due to its strong sedative properties, it is primarily used as an [[hypnotic]].
-| ATC_supplemental=
+Cinolazepam is not approved for sale in the United States or Canada.
-| PubChem=3033621
-| DrugBank=?
-| C=18 | H=13 | Cl=1 | F=1 | N=3 | O=2
-| molecular_weight = 357.8
-| bioavailability= 90-100%
-| metabolism = [[Liver|Hepatic]]
-| elimination_half-life= 9 h<ref name=half-life>{{cite journal | first = B. | last = Saletu | coauthors = G. Kindshofer, P. Anderer, J. Grunberger | year = 1987 | title = Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise. | journal = International Journal of Clinical Pharmacology Research | volume = 7 | issue = 5 | pages = 407-18 | id = {{PMID|2889679}} }}</ref>
-| excretion =  [[Kidney|Renal]]
-| pregnancy_category = ?
-| legal_status = [[Schedule IV controlled substance|Schedule IV]](US)
-| routes_of_administration= Oral
-}}
-'''Cinolazepam''' (Gerodorm®<ref name=Gerodorm>{{cite web | url = http://www.lannacher.ro/gerodorm.html | title = Gerodorm® | accessmonthday = 17 August | accessyear = 2006 | author = Lannacher Romania | year = 1999 | work = Produse Gerot inregistrate in Romania | language = Romanian}}</ref>) is a drug which is a [[benzodiazepine]] derivative. It possesses [[anxiolytic]], [[anticonvulsant]], [[sedative]] and [[skeletal muscle relaxant]] properties.
-Cinolazepam is not approved for sale in the United States or Canada.
+==See also==
+*[[Benzodiazepine]]
 ==References==
-<div class="references-small"><references/></div>
+{{Reflist|2}}
-==External links==
-* [http://www.inchem.org/documents/pims/pharm/pim920.htm Inchem.org - Cinolazepam]
 {{Benzodiazepines}}
 {{Hypnotics and sedatives}}
 [[Category:Benzodiazepines]]
 [[Category:Hypnotics]]
+[[Category:Organochlorides]]
+[[Category:Nitriles]]
-{{pharma-stub}}
+[[Category:Organofluorides]]
+[[Category:Lactams]]
-[[gl:Cinolazepam]]
+[[Category:Alcohols]]
-[[la:Cinolazepamum]]
+[[Category:Drug]]
-{{WikiDoc Help Menu}}

Cinolazepam: Difference between revisions

Latest revision as of 14:47, 8 April 2015

Overview

See also

References

Navigation menu